Hinge Health is trading at $83.85 (5.6% up) after posting a major second-quarter earnings beat and raising its full-year 2026 revenue guidance.
- The company announced a $105 million acquisition of Cylinder Health, a strategic move to expand its multi-condition platform into gastrointestinal care.
- Investors are reacting positively to the company’s accelerated growth trajectory and its evolution into a comprehensive healthcare provider.
- The price action builds on gains from earlier in the week, supported by a broader rally across the market and the healthcare sector.